EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections

Maria Siopi iD, Dimitrios Skliros iD, Paschalis Paranos iD, Nikoletta Koumasi, Emmanouil Flemetakis iD, Spyros Pournaras iD, Joseph Meletiadis iD

Clinical Microbiology Reviews · 12.09.2024 · 37 (3)

DOI: 10.1128/cmr.00044-24 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 12.09.2024. Verfasst von Maria Siopi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Microbiology Laboratory, Attikon University General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece. Hauptthemen laut MEDLINE: Phage Therapy, Drug Resistance, Multiple, Bacterial, Bacteriophages, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the early recognition of their therapeutic potential and the current escalation of multidrug-resistant (MDR) pathogens, the adoption of bacteriophages into mainstream clinical practice is hindered by unfamiliarity with their basic pharmacokinetic (PK) and pharmacodynamic (PD) properties, among others. Given the self-replicative nature of bacteriophages in the presence of host bacteria, the adsorption rate, and the clearance by the host’s immunity, their PK/PD characteristics cannot be estimated by conventional approaches, and thus, the introduction of new considerations is required. Furthermore, the multitude of different bacteriophage types, preparations, and treatment schedules impedes drawing general conclusions on their in vivo PK/PD features. Additionally, the drawback of acquired bacteriophage resistance of MDR pathogens with clinical and environmental implications should be taken into consideration. Here, we provide an overview of the current state of the field of PK and PD of bacteriophage therapy with a focus on its application against MDR Gram-negative infections, highlighting the potential knowledge gaps and the challenges in translation from the bench to the bedside. After reviewing the in vitro PKs and PDs of bacteriophages against the four major MDR Gram-negative pathogens, Klebsiella pneumoniae , Acinetobacter baumannii complex, Pseudomonas aeruginosa , and Escherichia coli , specific data on in vivo PKs (tissue distribution, route of administration, and basic PK parameters in animals and humans) and PDs (survival and reduction of bacterial burden in relation to the route of administration, timing of therapy, dosing regimens, and resistance) are summarized. Currently available data merit close scrutiny, and optimization of bacteriophage therapy in the context of a better understanding of the underlying PK/PD principles is urgent to improve its therapeutic effect and to minimize the occurrence of bacteriophage resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phage TherapyDrug Resistance, Multiple, BacterialBacteriophagesGram-Negative Bacterial InfectionsHumansAnimalsGram-Negative BacteriaAnti-Bacterial Agents

Stichwörter der Autor:innen

Gram-negative bacterial infectionsbacteriophage therapymultidrug-resistantpharmacodynamicspharmacokinetics

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Clinical Microbiology Laboratory, Attikon University General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Laboratory of Molecular Biology, Department of Biotechnology, School of Applied Biology and Biotechnology, Agricultural University of Athens, Athens, Greece.

ORCID-Profile: Maria Siopi, Dimitrios Skliros, Paschalis Paranos, Emmanouil Flemetakis, Spyros Pournaras, Joseph Meletiadis

Zitieren

APA

Siopi, M., Skliros, D., Paranos, P., Koumasi, N., Flemetakis, E., Pournaras, S., & Meletiadis, J. (2024). Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections. Clinical Microbiology Reviews, 37(3). https://doi.org/10.1128/cmr.00044-24

Vancouver

Siopi M, Skliros D, Paranos P, Koumasi N, Flemetakis E, Pournaras S, et al. Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections. Clinical Microbiology Reviews. 2024;37(3). doi:10.1128/cmr.00044-24

BibTeX
@article{Siopi2024,
  author = {Siopi, Maria and Skliros, Dimitrios and Paranos, Paschalis and Koumasi, Nikoletta and Flemetakis, Emmanouil and Pournaras, Spyros and Meletiadis, Joseph},
  title = {Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections},
  journal = {Clinical Microbiology Reviews},
  year = {2024},
  volume = {37},
  number = {3},
  doi = {10.1128/cmr.00044-24}
}
Kostenlos starten →